Mercury Laboratories Ltd.
| BSE: 538964 | Sector: Health care |
| NSE: N.A. | ISIN Code: INE947G01011 |
| BSE 10:39 | 24 Sep | 682.00 |
-2.00 (-0.29%) |
OPEN
682.00 |
HIGH
682.00 |
LOW
682.00 |
| NSE 05:30 | 01 Jan | Mercury Laboratories Ltd |
| OPEN | 682.00 |
| PREVIOUS CLOSE | 684.00 |
| VOLUME | 295 |
| 52-Week high | 937.00 |
| 52-Week low | 366.00 |
| P/E | 14.55 |
| Mkt Cap.(Rs cr) | 82 |
| Buy Price | 675.00 |
| Buy Qty | 18.00 |
| Sell Price | 709.00 |
| Sell Qty | 10.00 |
Mercury Laboratories Ltd. (MERCURYLABS) - Net Profit
Net Profit
| COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Profit (Rs crore) |
| Aurobindo Pharma | 729.00 | -4.60 | -0.63 | 3112.91 |
| Cipla | 978.00 | 9.95 | 1.03 | 2468.28 |
| Dr Reddy's Labs | 4800.00 | 4.00 | 0.08 | 2186.40 |
| Sun Pharma.Inds. | 772.55 | 2.80 | 0.36 | 2139.70 |
| Divi's Lab. | 5177.85 | -35.00 | -0.67 | 1954.72 |
| Alkem Lab | 3986.20 | 22.00 | 0.55 | 1685.08 |
| Glenmark Pharma. | 508.40 | -3.70 | -0.72 | 1649.45 |
| Cadila Health. | 564.35 | -2.55 | -0.45 | 1476.20 |
| Lupin | 937.45 | -2.95 | -0.31 | 1258.62 |
| Alembic Pharma | 804.90 | -15.00 | -1.83 | 1175.39 |
| Ipca Labs. | 2441.10 | -34.45 | -1.39 | 1140.77 |
| Torrent Pharma. | 3097.05 | -5.15 | -0.17 | 1137.85 |
| Gland Pharma | 3894.05 | -16.05 | -0.41 | 997.01 |
| Laurus Labs | 613.40 | -8.55 | -1.37 | 956.11 |
| Abbott India | 21541.00 | -47.45 | -0.22 | 690.69 |
| Ajanta Pharma | 2174.50 | -9.30 | -0.43 | 675.64 |
| Wockhardt | 430.20 | -2.70 | -0.62 | 593.29 |
| Granules India | 324.60 | 3.15 | 0.98 | 552.78 |
| Pfizer | 5820.10 | -1.20 | -0.02 | 497.61 |
| Sanofi India | 8138.00 | -60.75 | -0.74 | 477.60 |
Quick Links for Mercury Laboratories:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
